DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cerubidine (Daunorubicin) - Sepsis - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Sepsis (10)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cerubidine (Daunorubicin) where reactions include sepsis. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Cerubidine side effects in 44 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-08

Patient: 44 year old female

Reactions: Gastrointestinal Haemorrhage, Haemorrhage, Lung Disorder, Mesenteric Panniculitis, Sepsis, Febrile Bone Marrow Aplasia, Bone Marrow Failure, Infection

Drug(s) suspected as cause:
Cerubidine



Possible Cerubidine side effects in 44 year old female

Reported by a physician from France on 2012-07-27

Patient: 44 year old female

Reactions: Lung Disorder, Gastrointestinal Haemorrhage, Mesenteric Panniculitis, Sepsis, Febrile Bone Marrow Aplasia

Drug(s) suspected as cause:
Mylotarg
    Dosage: 10.4 mg, 1x/day
    Indication: Acute Leukaemia
    Start date: 2008-07-25
    End date: 2008-07-25

Cytarabine
    Dosage: 348 mg, 1x/day
    Indication: Acute Leukaemia
    Start date: 2008-07-22
    End date: 2008-07-28

Cerubidine
    Dosage: 104.4 mg, 1x/day
    Indication: Acute Leukaemia
    Start date: 2008-07-22
    End date: 2008-07-24



Possible Cerubidine side effects in 44 year old female

Reported by a physician from France on 2012-07-13

Patient: 44 year old female

Reactions: Gastrointestinal Haemorrhage, Lung Disorder, Mesenteric Panniculitis, Sepsis, Febrile Bone Marrow Aplasia

Drug(s) suspected as cause:
Cerubidine
    Dosage: 104.4 mg, 1x/day
    Indication: Acute Leukaemia
    Start date: 2008-07-22
    End date: 2008-07-24

Mylotarg
    Dosage: 10.4 mg, 1x/day
    Indication: Acute Leukaemia
    Start date: 2008-07-25
    End date: 2008-07-25

Cytarabine
    Dosage: 348 mg, 1x/day
    Indication: Acute Leukaemia
    Start date: 2008-07-22
    End date: 2008-07-28



Possible Cerubidine side effects in 5 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-01-16

Patient: 5 year old male, weighing 18.0 kg (39.6 pounds)

Reactions: Sepsis, Generalised Oedema

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Gleevec
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-13
    End date: 2011-10-21

Cyclophosphamide
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-01

Kidrolase
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-14

Methotrexate
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-03
    End date: 2011-10-14

Vincristine Sulfate
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-13

Cerubidine
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-13

Cytarabine
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-10
    End date: 2011-10-14



Possible Cerubidine side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-01-09

Patient: male, weighing 18.0 kg (39.6 pounds)

Reactions: Urine Output Decreased, Pyrexia, Aplasia, Stomatococcal Infection, Pericardial Effusion, Generalised Oedema, Ascites, Staphylococcal Infection, Spleen Disorder, Oral Disorder, Sepsis, Hypoxia, Acute Respiratory Distress Syndrome, Pleural Effusion, Candidiasis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 25 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-10
    End date: 2011-10-14

Gleevec
    Dosage: 200 mg, qd
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-13
    End date: 2011-10-21

Cerubidine
    Dosage: 31 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-13

Methotrexate
    Dosage: 12 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-03
    End date: 2011-10-14

Vincristine
    Dosage: 1.2 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-13

Kidrolase
    Dosage: 4800 iu, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-14

Cyclophosphamide
    Dosage: 780 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06



Possible Cerubidine side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-01-09

Patient: male, weighing 18.0 kg (39.6 pounds)

Reactions: Urine Output Decreased, Pyrexia, Stomatococcal Infection, Aplasia, Generalised Oedema, Ascites, Pericardial Effusion, Staphylococcal Infection, Oral Disorder, Sepsis, Hypoxia, Pleural Effusion, Acute Respiratory Distress Syndrome, Candidiasis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Gleevec
    Dosage: 200 mg, qd
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-13
    End date: 2011-10-21

Cyclophosphamide
    Dosage: 780 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06

Cytarabine
    Dosage: 25 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-10
    End date: 2011-10-14

Methotrexate
    Dosage: 12 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-03
    End date: 2011-10-14

Vincristine
    Dosage: 1.2 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-13

Kidrolase
    Dosage: 4800 iu, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-14

Cerubidine
    Dosage: 31 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-13



Possible Cerubidine side effects in 5 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-01-05

Patient: 5 year old male, weighing 18.0 kg (39.6 pounds)

Reactions: Sepsis, Generalised Oedema

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Gleevec
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-13
    End date: 2011-10-21

Cerubidine
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-13

Methotrexate
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-03
    End date: 2011-10-14

Cytarabine
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-10
    End date: 2011-10-14

Kidrolase
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-14

Cyclophosphamide
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-01

Vincristine Sulfate
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-10-06
    End date: 2011-10-13



Possible Cerubidine side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-01-02

Patient: male, weighing 18.0 kg (39.6 pounds)

Reactions: Urine Output Decreased, Pyrexia, Stomatococcal Infection, Aplasia, Ascites, Pericardial Effusion, Generalised Oedema, Staphylococcal Infection, Oral Disorder, Sepsis, Hypoxia, Pleural Effusion, Acute Respiratory Distress Syndrome, Candidiasis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Kidrolase
    Dosage: 4800 iu, unk
    Start date: 2011-10-06
    End date: 2011-10-14

Cerubidine
    Dosage: 31 mg, unk
    Start date: 2011-10-06
    End date: 2011-10-13

Cytarabine
    Dosage: 25 mg, unk
    Start date: 2011-10-10
    End date: 2011-10-14

Cyclophosphamide
    Dosage: 780 mg, unk
    Start date: 2011-10-06

Vincristine Sulfate
    Dosage: 1.2 mg, unk
    Start date: 2011-10-06
    End date: 2011-10-13

Gleevec
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2011-10-13
    End date: 2011-10-21

Methotrexate
    Dosage: 12 mg, unk
    Start date: 2011-10-03
    End date: 2011-10-14



Possible Cerubidine side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2011-12-31

Patient: male, weighing 18.0 kg (39.6 pounds)

Reactions: Urine Output Decreased, Pyrexia, Stomatococcal Infection, Aplasia, Pericardial Effusion, Generalised Oedema, Ascites, Staphylococcal Infection, Oral Disorder, Sepsis, Pleural Effusion, Hypoxia, Acute Respiratory Distress Syndrome, Candidiasis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Vincristine Sulfate
    Dosage: 1.2 mg, unk
    Start date: 2011-10-06
    End date: 2011-10-13

Cytarabine
    Dosage: 25 mg, unk
    Start date: 2011-10-10
    End date: 2011-10-14

Cerubidine
    Dosage: 31 mg, unk
    Start date: 2011-10-06
    End date: 2011-10-13

Methotrexate
    Dosage: 12 mg, unk
    Start date: 2011-10-03
    End date: 2011-10-14

Gleevec
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2011-10-13
    End date: 2011-10-21

Cyclophosphamide
    Dosage: 780 mg, unk
    Start date: 2011-10-06

Kidrolase
    Dosage: 4800 iu, unk
    Start date: 2011-10-06
    End date: 2011-10-14



Possible Cerubidine side effects in 52 year old male

Reported by a physician from France on 2011-10-14

Patient: 52 year old male

Reactions: Sepsis, Device Related Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Gemtuzumab Ozogamicin
    Dosage: 11.4 mg, 1x/day
    Indication: Acute Leukaemia
    Start date: 2010-03-29
    End date: 2010-03-29

Cytarabine
    Dosage: 380 mg, 1x/day
    Indication: Acute Leukaemia
    Start date: 2010-03-25
    End date: 2010-03-31

Cerubidine
    Dosage: 114 mg, 1x/day
    Indication: Acute Leukaemia
    Start date: 2010-03-25
    End date: 2010-03-27

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017